Michel Burnier

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


907 publications

... | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ...
2012
 
Preserved capillary density of dorsal finger skin in treated hypertensive patients with or without type 2 diabetes.
Aellen J., Dabiri A., Heim A., Liaudet L., Burnier M., Ruiz J., Feihl F., Waeber B., 2012. Microcirculation, 19 (6) pp. 554-562.
[DOI][WoS][Pmid][serval:BIB_A1D45229DC52]
 
Quelles applications raisonnables pour l'anticoagulation régionale au citrate en épuration extrarénale [What reasonable applications for regional citrate anticoagulation in renal replacement therapy?].
Kissling S., Wilson P., Ridel C., Burnier M., Vogt B., 2012. Revue Médicale Suisse, 8 (330) pp. 452-456.
[Pmid][serval:BIB_CC48F2A367B7]
Renal perfusion evaluation with contrast-enhanced ultrasonography.
Schneider A.G., Hofmann L., Wuerzner G., Glatz N., Maillard M., Meuwly J.Y., Eggimann P., Burnier M., Vogt B., 2012. Nephrology, Dialysis, Transplantation, 27 (2) pp. 674-681. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0FBD29996D50]
Role of the renal circadian timing system in maintaining water and electrolytes homeostasis.
Firsov D., Tokonami N., Bonny O., 2012. Molecular and Cellular Endocrinology, 349 (1) pp. 51-55.
[URN][DOI][WoS][Pmid][serval:BIB_B81E53EE97B7]
 
Short-term increase in particulate matter blunts nocturnal blood pressure dipping and daytime urinary sodium excretion
Tsai Dai-Hua, Riediker Michael, Wuerzner Grégoire, Maillard Marc, Marques-Vidal Pedro, Paccaud Fred, Vollenweider Peter, Burnier Michel, Bochud Murielle, 2012. Hypertension, 60 (4) pp. 1061-1069. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F84D6A7C8903]
 
Should hypertensive patients take vitamin d?
Wuerzner G., Burnier M., Waeber B., 2012. Current Hypertension Reports, 14 (4) pp. 318-323.
[DOI][WoS][Pmid][serval:BIB_0E399038C849]
The circadian clock modulates renal sodium handling.
Nikolaeva S., Pradervand S., Centeno G., Zavadova V., Tokonami N., Maillard M., Bonny O., Firsov D., 2012. Journal of the American Society of Nephrology, 23 (6) pp. 1019-1026. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4E9C79612EC0]
 
Transpiration stimulée afin d'améliorer l'équilibre hydro-sodé chez les patients hémodialysés : à propos d'un cas [Stimulated sweating in order to improve the water-and-salt balance in hemodialysis patients. A case report].
El-Housseini Y., Mahfoudh H., Jarraya F., Hachicha J., Teta D., Burnier M., Pruijm M., 2012. Néphrologie et Thérapeutique, 8 (6) pp. 472-475.
[DOI][WoS][Pmid][serval:BIB_E07EBB1E7393]
 
Troubles du sommeil chez des patients présentant une insuffisance rénale chronique [Sleep disorders in patients with chronic renal insufficiency].
Muller M.E., Heinzer R., Pruijm M., Wuerzner G., Burnier M., 2012. Revue Médicale Suisse, 8 (330) pp. 458-461.
[Pmid][serval:BIB_6596D1C54386]
Usefulness of Telemetric Blood Pressure Monitoring in Hypertensive Patients with Chronic Kidney Diseases
Burnier M., Bock A., Halabi G., Gasser U.E., Pechère Bertschi A., Ambühl P., Forster C., Gabutti L., Giovannini M., Hess B. et al., 2012. Journal of Nephrology and Therapeutics, 2 (5) pp. 1-6.
[URN][DOI][serval:BIB_D91C11A7F717]
 
Utilité des outils d'aide à la prise médicamenteuse pour améliorer l'adhésion au traitement: revue Cochrane pour le praticien
Santschi Valérie, Burnier Michel, Peytremann Bridevaux Isabelle, 2012. Revue médicale suisse, 8 (336) p. 816.
[serval:BIB_C165B3D2D57B]
2011
Traitement et prophylaxie de la Maladie ThromboEmbolique Veineuse (MTEV)
Centre hospitalier universitaire vaudois, Policlinique médicale universitaire (Lausanne) , 2011/05. 2 p..
[URN][serval:BIB_EFE579EC6162]
Haemodynamic consequences of changing potassium concentrations in haemodialysis fluids.
Gabutti L., Salvadé I., Lucchini B., Soldini D., Burnier M., 2011/04. Bmc Nephrology, 12 p. 14. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_655A020669E3]
Mise en place percutanée de filtres dans la veine cave inférieure en prévention de l'embolie pulmonaire : recommandations
Mazzolai L., Qanadli S., 2011/04. 7 p..
[URN][serval:BIB_D67D89778302]
Development of an erythropoietin prescription simulator to improve abilities for the prescription of erythropoietin stimulating agents: is it feasible?
Gabutti L., Nobile F., Forni V., Rigamonti F., Weibel N., Burnier M., 2011/02. Bmc Nephrology, 12 p. 11. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_91D485102A92]
 
Ambulatory blood pressure monitoring in diabetic patients: new data, new questions.
Burnier M., Grassi G., 2011. Journal of Hypertension, 29 (2) pp. 198-200.
[DOI][WoS][Pmid][serval:BIB_A0E357DF5CF8]
 
Ambulatory blood pressure monitoring to assess cardiovascular risk in women.
Waeber B., Burnier M., 2011. Hypertension, 57 (3) pp. 377-378.
[DOI][WoS][Pmid][serval:BIB_3E7F659D7F0E]
 
Antagonistes de l'angiotensine II et cancer: un bilan rassurant [Angiotensin II receptor blockers (ARBs) and cancer: a reassuring balance].
Cassat M., Wuerzner G., Burnier M., Waeber B., 2011. Revue Médicale Suisse, 7 (308) pp. 1757-1760.
[Pmid][serval:BIB_AF1650250FDF]
 
Bicarbonate de sodium pour ralentir la progression de la maladie rénale chronique [Sodium bicarbonate to slow the progression of chronic kidney disease].
Rossier A., Bullani R., Burnier M., Teta D., 2011. Revue Médicale Suisse, 7 (284) pp. 478-482.
[Pmid][serval:BIB_663947E03E41]
 
Caffeine intake is associated with reduced risk of hypertension in non-smokers.
Guessous Idris, Pruijm Menno T., Paccaud Fred, Mooser Vincent, Burnier Michel, Waeber Gérard, Gaspoz Jean-Michel, Vollenweider Peter, Bochud Murielle, 2011. pp. e107 dans 21st European Meeting on Hypertension and Cardiovascular Prevention, Milan, Italy, June 17-20, 2011, Journal of Hypertension. Peer-reviewed.
[serval:BIB_913B828AC9CE]
 
Calcium, vitamin D and cardiovascular disease.
Guessous Idris, Bochud Murielle, Bonny Olivier, Burnier Michel, 2011. Kidney and Blood Pressure Research, 34 (6) pp. 404-417. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_40E2B5671312]
 
Challenges in recruiting participants in a population-based survey including 24-hour urine collection: example from the Swiss Survey on Salt Intake.
Chappuis Aline, Glatz Nicolas, Vuistiner Philippe, Forni Valentina, Paccaud Fred, Burnier Michel, Bochud Murielle, 2011. pp. 23S dans Annual meeting of the Swiss Society of Nephrology, Montreux, Switzerland, November 30-December 2, 2011, Suppl. 191. Peer-reviewed.
[serval:BIB_ECD6A68F8371]
 
Circadian rythm of renal urate handling in the general population.
Bochud Murielle, Maillard Marc P., Lyngdoh Tanica, Vollenweider Peter, Paccaud Fred, Burnier Michel, 2011. pp. e111 dans 21st European Meeting on Hypertension and Cardiovascular Prevention, Milan, Italy, June 17-20, 2011, Journal of Hypertension. Peer-reviewed.
[serval:BIB_ACC66666C7A2]
 
Combining blockers of the renin-angiotensin system or increasing the dose of an angiotensin II receptor antagonist in proteinuric patients: a randomized triple-crossover study.
Meier P., Maillard M.P., Meier J.R., Tremblay S., Gauthier T., Burnier M., 2011. Journal of Hypertension, 29 (6) pp. 1228-1235.
[DOI][WoS][Pmid][serval:BIB_C9943169D7DF]
Critical review of cancer risk associated with angiotensin receptor blocker therapy.
Wuerzner G., Burnier M., Waeber B., 2011. Vascular Health and Risk Management, 7 pp. 741-747.
[URN][DOI][Pmid][serval:BIB_4170A7F17199]
 
Daytime and nighttime urinary steroids in the Swiss Kidney Project on Genes in Hypertension.
Ackermann Daniel, Ehret Georg B., Guessous Idris, Ponte Belén, Pruijm Menno T., Dick Bernhard, Burnier Michel, Frey Felix, Martin Pierre-Yves, Paccaud Fred et al., 2011. pp. e473 dans 21st European Meeting on Hypertension and Cardiovascular Prevention, Milan, Italy, June 17-20, 2011, Journal of Hypertension. Peer-reviewed.
[serval:BIB_BA3F86E733B5]
 
Denervation rénale endovascu- laire par radiofréquence: perspective d'un traitement prometteur de l'hypertension artérielle [Renal sympathetic denervation: perspective of a promising treatment for hypertension].
Cassat M., Wuerzner G., Pruijm M., Forni V., Burnier M., 2011. Revue Médicale Suisse, 7 (308) pp. 1743-1747.
[Pmid][serval:BIB_B56140037ACC]
 
Diabète et insuffisance rénate terminate. Evolution en huit ans dans le canton de Vaud [Diabetes and end stage renal disease. Eight year progression in the Canton de Vaud, Switzerland].
Stamm C., Burnier M., Zanchi A., 2011. Revue Médicale Suisse, 7 (284) pp. 495-499.
[Pmid][serval:BIB_86595ACCB86C]
 
Effect of intradialytic resistance band exercise on physical function in patients on maintenance hemodialysis: a pilot study.
Bullani R., El-Housseini Y., Giordano F., Larcinese A., Ciutto L., Coti Bertrand P., Wuerzner G., Burnier M., Teta D., 2011. Journal of Renal Nutrition, 21 (1) pp. 61-65.
[DOI][WoS][Pmid][serval:BIB_E931F1AEAF4D]
 
Effects of pioglitazone on renal calcium excretion.
Zanchi A., Pechère-Bertschi A., Burnier M., Bonny O., 2011. Journal of Clinical Endocrinology and Metabolism, 96 (9) pp. E1482-E1485.
[DOI][WoS][Pmid][serval:BIB_E58C3CDE505B]
 
Effects on blood pressure and cardiovascular risk of variations in patients' adherence to prescribed antihypertensive drugs: role of duration of drug action.
Lowy A., Munk V.C., Ong S.H., Burnier M., Vrijens B., Tousset E.P., Urquhart J., 2011. International Journal of Clinical Practice, 65 (1) pp. 41-53.
[DOI][WoS][Pmid][serval:BIB_BB089775928A]
 
FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone.
Wöhrle S., Bonny O., Beluch N., Gaulis S., Stamm C., Scheibler M., Müller M., Kinzel B., Thuery A., Brueggen J. et al., 2011. Journal of Bone and Mineral Research, 26 (10) pp. 2486-2497.
[DOI][WoS][Pmid][serval:BIB_364281994870]
 
Funding: The Scientific Cooperation Between Eastern Europe and Switzerland Programme
Taylor J., Burnier M., Abriel H., 2011. Circulation, 124 (22) pp. F130-132. Peer-reviewed.
[serval:BIB_35FB47E408A5]
 
Heritability of steroid synthesis in the Swiss Kidney Project on Genes in Hypertension.
Ackermann Daniel, Ehret Georg B., Guessous Idris, Ponte Belén, Pruijm Menno T., Dick Bernhard, Burnier Michel, Frey Felix, Martin Pierre-Yves, Paccaud Fred et al., 2011. pp. e334 dans 1st European Meeting on Hypertension and Cardiovascular Prevention, Milan, Italy, June 17-20, 2011, Journal of Hypertension. Peer-reviewed.
[serval:BIB_B97937357228]
 
Higher physical activity is associated with lower nighttime systolic blood variability: a cross sectional study.
Wuerzner Grégoire, Bochud Murielle, Pruijm Menno T., Zweiacker Carole, Tremblay Sylvie, Burnier Michel, 2011. pp. e307 dans 21st European Meeting on Hypertension and Cardiovascular Prevention, Milan, Italy, June 17-20, 2011, Journal of Hypertension. Peer-reviewed.
[serval:BIB_327F625970C9]
 
Hypertension et vitamine D: retour sur la scène [Hypertension and vitamin D: not again].
Wuerzner G., Burnier M., Waeber B., 2011. Revue Médicale Suisse, 7 (278) pp. 121-124.
[Pmid][serval:BIB_732977AD965D]
 
Impact of prolonged antihypertensive duration of action on predicted clinical outcomes in imperfectly adherent patients: comparison of aliskiren, irbesartan and ramipril.
Burnier M., Brede Y., Lowy A., 2011. International Journal of Clinical Practice, 65 (2) pp. 127-133.
[DOI][WoS][Pmid][serval:BIB_9995498467BE]
 
Increased daytime proximal sodium reabsorption is associated with reduced nocturnal blood pressure dipping in the general population.
Bochud Murielle, Wuezner Grégoire, Maillard Marc, Beggah Ahmed, Vollenweider Peter, Paccaud Fred, Burnier Michel, 2011. pp. e6-e7 dans 21st European Meeting on Hypertension and Cardiovascular Prevention, Milan, Italy, June 17-20, 2011, Journal of Hypertension. Peer-reviewed.
[serval:BIB_AC083CE96D51]
 
Inflammatory markers and blood pressure: sex differences and the confounding effect of fat mass in the Colaus study.
Pruijm Menno T., Vollenweider Peter, Paccaud Fred, Preisig Marti, Waeber Gérard, Marques-Vidal Pedro Manuel, Burnier Michel, Bochud Murielle, 2011. pp. e147 dans 21st European Meeting on Hypertension and Cardiovascular Prevention, Milan, Italy, June 17-20, 2011, Journal of Hypertension. Peer-reviewed.
[serval:BIB_DB5E648A1CBE]
 
Les antagonistes des récep- teurs de l'endothéline ont-ils une place dans le traitement de l'hyper- tension artérielle [Do endothelin receptors antagonists have a place in the treatment of arterial hypertension?].
Forni V., Wuerzner G., Pruijm M., Cassat M., Menetrey I., Burnier M., 2011. Revue Médicale Suisse, 7 (308) pp. 1752-1756.
[Pmid][serval:BIB_ECCC90A207F4]
Long-term use and tolerability of irbesartan for control of hypertension.
Forni V., Wuerzner G., Pruijm M., Burnier M., 2011. Integrated Blood Pressure Control, 4 pp. 17-26.
[URN][DOI][Pmid][serval:BIB_17121672F6CF]
 
Lowering systolic blood pressure below 130 mm Hg does not improve cardiovascular outcomes in hypertensive patients with diabetes and coronary artery disease.
Burnier M., Wuerzner G., 2011. Evidence-Based Medicine, 16 (1) pp. 24-26.
[DOI][Pmid][serval:BIB_78FD07EA0365]
 
Measurement of glomerular filtration rate in obese patients: pitfalls and potential consequences on drug therapy.
Wuerzner G., Bochud M., Giusti V., Burnier M., 2011. Obesity Facts, 4 (3) pp. 238-243. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4F6EB15BC030]
 
Nouvelles techniques radiologiques pour les patients insuffisants rénaux [New radiological techniques to investigate patients suffering from chronic kidney disease].
Pruijm M., Ponte B., Hofmann L., Vogt B., Eisenberger U., Meuwly J.Y., Burnier M., 2011. Revue Médicale Suisse, 7 (284) pp. 505-509.
[Pmid][serval:BIB_77375869ED82]
Nutrition in cardiovascular disease: salt in hypertension and heart failure.
He F.J., Burnier M., Macgregor G.A., 2011. European Heart Journal, 32 (24) pp. 3073-3080. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_96B9564999AC]
 
Obesity is associated with increased daytime and night-time proximal tubular sodium reabsorption in the general adult population.
Bochud Murielle, Wuerzner Grégoire, Maillard Marc, Vollenweider Peter, Paccaud Fred, Burnier Michel, 2011. pp. e6 dans 21st European Meeting on Hypertension and Cardiovascular Prevention, Milan, Italy, June 17-20, 2011, Journal of Hypertension. Peer-reviewed.
[serval:BIB_BB544A235C7F]
 
Passe-moi le sel [Pass the salt!].
Pechère-Bertschi A., Waeber B., Burnier M., 2011. Revue Médicale Suisse, 7 (308) pp. 1731-1732.
[Pmid][serval:BIB_AE0DFC9C3868]
 
Pharmacokinetic evaluation of losartan.
Burnier M., Wuerzner G., 2011. Expert Opinion on Drug Metabolism and Toxicology, 7 (5) pp. 643-649.
[DOI][WoS][Pmid][serval:BIB_C55118C53D15]
 
Prevalence of chronic kidney disease in the adult population of Lausanne (CoLaus study).
Ponte Belén, Bochud Murielle, Pruijm Menno T., Martin Pierre-Yves, Burnier Michel, Paccaud Fred, Mooser Vincent, Waeber Gérard, Vollenweider Peter, 2011. pp. 3S dans 79e Assemblée annuelle de la Société suisse de médecine interne générale, Lausanne, Suisse, 11-13 mai 2011, Swiss Medical Forum.
[URN][serval:BIB_20DD6D3C7E32]
 
Profitieren ältere Hypertoniker von einer medikamentösen Therapie? [Do elderly hypertensive patients benefit from drug therapy?].
Santschi Valérie, Burnier Michel, Peytremann-Bridevaux Isabelle, 2011. Praxis, 100 (12) pp. 731-732.
[DOI][Pmid][serval:BIB_F3009D5F97FA]
 
Quel partenaire pour la néphrologie [What is the best partner for nephrology?].
Burnier M., Martin P.Y., 2011. Revue Médicale Suisse, 7 (284) p. 475.
[Pmid][serval:BIB_0105F96EF7D9]
 
Referral patterns and outcomes in noncritically ill patients with hospital-acquired acute kidney injury.
Meier P., Meier Bonfils R., Vogt B., Burnand B., Burnier M., 2011. Clinical Journal of the American Society of Nephrology, 6 (9) pp. 2215-2225. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_38F3632725F0]
 
Rituximab dans le traitement des maladies rénales glomérulaires: indications et evidences cliniques [Rationale and clinical evidence for the use of rituximab in glomerular diseases].
Mani L.Y., Vogt B., Burnier M., Golshayan D., 2011. Revue Médicale Suisse, 7 (290) pp. 819-824.
[Pmid][serval:BIB_9BB934CAAB4D]
Swiss survey on salt intake: main results
Chappuis Aline, Bochud Murielle, Glatz Nicolas, Vuistiner Philippe, Paccaud Fred, Burnier Michel, 2011. 32, Lausanne : Centre Hospitalier Universitaire Vaudois (CHUV), Service de néphrologie et Institut universitaire de médecine sociale et préventive (IUMSP),.
[URN][serval:BIB_16AEF897B618]
Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine.
Bochud M., Burnier M., Guessous I., 2011. Current Pharmacogenomics and Personalized Medicine, 9 (4) pp. 299-322. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_02D430784634]
2010
 
Réduction de la consommation de sel: une mesure importante de santé publique en Suisse [Reducing dietary salt intake: an important public health strategy in Switzerland]
Bochud M., Burnier M., Marques-Vidal P.M., Paccaud F., 2010/03/10. Revue medicale suisse, 6 (239) pp. 494,496-498. Peer-reviewed.
[Pmid][serval:BIB_DF4BAEF56319]
 
A new technique for simultaneous validation of two manual nonmercury auscultatory sphygmomanometers (A&D UM-101 and Accoson Greenlight 300) based on the International protocol.
Pruijm M.T., Wuerzner G., Glatz N., Alwan H., Ponte B., Ackermann D., Burnier M., Bochud M., 2010. Blood Pressure Monitoring, 15 (6) pp. 322-325.
[DOI][WoS][Pmid][serval:BIB_9D378877A2E7]
 
Adiponectin and C-reactive protein are positively associated with microalbuminuria in an adult Caucasian population
Pruijm Menno, Vollenweider Peter, Mooser Vincent, Marques-Vidal Pedro Manuel, Teta Daniel, Paccaud Fred, Waeber Gérard, Burnier Michel, Bochud Murielle, 2010. pp. E558-E558 dans 20th Annual Meeting of the European Society of Hypertension, Journal of Hypertension. Peer-reviewed.
[DOI][WoS][serval:BIB_68A7CE845E5F]
 
Adiponectin and C-reactive protein are positively associated with microalbuminuria in an adult Caucasian population
Pruijm Menno T., Vollenweider P., Mooser V., Teta D., Paccaud F., Marques-Vidal P.M., Waeber G., Burnier M., Bochud M., 2010. pp. 29S dans 78. Jahresversammlung der Schweizerischen Gesellschaft für Innere Medizin, Swiss Medical Forum = Forum Médical Suisse.
[serval:BIB_3B4969CADEA7]
 
Alimentation et hypertension artérielle: au-delà du sel de table [Nutrition and hypertension: more than table salt].
Pruijm M., Wuerzer G., Forni V., Bochud M., Pechère-Bertschi A., Burnier M., 2010. Revue Médicale Suisse, 6 (262) pp. 1715-1720.
[Pmid][serval:BIB_AE6E618714B0]
Anemia and chronic kidney disease are potential risk factors for mortality in stroke patients: a historic cohort study.
Del Fabbro Patrizia, Luthi Jean-Christophe, Carrera Emmanuel, Michel Patrik, Burnier Michel, Burnand Bernard, 2010. BMC Nephrology, 11 pp. art. 27 [10 p.]. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D3E900EB9CC6]
Antagonistes de l'angiotensine II et cancer : un orage qui peut faire du bien
Waeber B., Péchère-Bertschi A., Burnier M., 2010. HTA-INFO 29 pp. 19-20.
[URN][serval:BIB_051D9A9F3941]
 
Antagonistes de l'angiotensine II et cancer: un orage qui peut faire du bien [Angiotensin II antagonists and cancer: a storm that can do good ].
Waeber B., Pechère-Bertschi A., Burnier M., 2010. Revue Médicale Suisse, 6 (262) pp. 1691-1692.
[Pmid][serval:BIB_342AE27DB4DA]
Cardiac hypertrophy, low blood pressure, and low aldosterone levels in mice devoid of the three circadian PAR bZip transcription factors DBP, HLF, and TEF.
Wang Q., Maillard M., Schibler U., Burnier M., Gachon F., 2010. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 299 (4) pp. R1013-R1019. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E62BDCCFF932]
 
Comparative vascular and renal tubular effects of angiotensin II receptor blockers combined with a thiazide diuretic in humans.
Coltamai Lionel, Maillard Marc, Simon Alexandra, Vogt Bruno, Burnier Michel, 2010. Journal of Hypertension, 28 (3) pp. 520-526.
[DOI][WoS][Pmid][serval:BIB_34B726B025FF]
 
Development of Implantable Flow-Through Left Ventricular Pressure Telemetric Transmitter for small Rodent Animals
Wang Q., Van Lintel H., Yanisse D., Burnier M., Renaud P., 2010. pp. E257 dans 20th Annual Meeting of the European-Society-of-Hypertension, Journal of Hypertension. Peer-reviewed.
[WoS][serval:BIB_6BD563B27341]
 
Effect of sodium loading/depletion on renal oxygenation in young normotensive and hypertensive men.
Pruijm M., Hofmann L., Maillard M., Tremblay S., Glatz N., Wuerzner G., Burnier M., Vogt B., 2010. Hypertension, 55 (5) pp. 1116-1122.
[DOI][WoS][Pmid][serval:BIB_6B4E84BB5150]
 
Effects of intradialytic resistance band exercice on physical function in patients on maintenance haemodialysis : a pilot study
Bullani R., Ed Housseini Y., Giordano F., Larcinese A., Ciutto L., Coti Bertrand P., Wuerzner G., Burnier M., Teta D., 2010. dans 15th International Congress on Nutrition and Metabolism (ICRNM).
[serval:BIB_E04502261333]
 
Effects of pioglitazone on body fat distribution in dialysed non diabetic subjects
Zanchi A., Tappy L., Theumann N., Halabi G., Gauthier T., Mathieu C., Von Albertini B., Ciutto C., Coti Bertrand P., Burnier M. et al., 2010. dans 15th International Congress on Nutrition and Metabolism (ICRNM).
[serval:BIB_2E2422038D0B]
Effects of the peroxisome proliferator-activated receptor (PPAR)-gamma agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals.
Zanchi A., Maillard M., Jornayvaz F.R., Vinciguerra M., Deleaval P., Nussberger J., Burnier M., Pechere-Bertschi A., 2010. Diabetologia, 53 (8) pp. 1568-1575.
[URN][DOI][WoS][Pmid][serval:BIB_2DCD23BF24A5]
Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension.
Padmanabhan Sandosh, Melander Olle, Johnson Toby, Di Blasio Anna Maria, Lee Wai K., Gentilini Davide, Hastie Claire E., Menni Cristina, Monti Maria Cristina, Delles Christian et al., 2010. Plos Genetics, 6 (10) pp. e1001177. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_88EC5A692A5D]
Glomerular hyperfiltration and increased proximal sodium reabsorption in subjects with type 2 diabetes or impaired fasting glucose in a population of the African region.
Pruijm M., Wuerzner G., Maillard M., Bovet P., Renaud C., Bochud M., Burnier M., 2010. Nephrology, Dialysis, Transplantation, 25 (7) pp. 2225-2231. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8F0FAE77FCA2]
 
Hypernatrémie: une question d'eau [Hypernatremia: a matter of water]
Berwert L., Vogt B., Burnier M., 2010. Revue Médicale Suisse, 6 (238) pp. 444-447.
[Pmid][serval:BIB_84D8354DED93]
 
Hypertension
Pasche O., Widmeier A., Cornuz J., Burnier M., Waeber B., 2010. pp. 249-263 dans Cornuz J., Pasche O. (eds.) COMPAS : stratégies de prise en charge clinique, Médecine et Hygiène.
[serval:BIB_DB7D94080394]
 
Inflammatory markers and association with kidney function in the general population
Pruijm Menno T., Vollenweider Peter, Mooser Vincent, Paccaud Fred, Waeber Gérard, Marques-Vidal Pedro Manuel, Burnier Michel, Bochud Murielle, 2010. pp. 11S dans Annual meeting of the Swiss Society of Nephrology, Lugano, Switzerland, December 1-3, 2010, Swiss Medical Weekly. Peer-reviewed.
[WoS][serval:BIB_301B66F0431C]
 
Insuffisance rénale severe sur maladie des emboles de cholestérol: controverses thérapeutiques revisitées [Severe renal insufficiency secondary to renal cholesterol emboli: therapeutical options revisited]
Simon R., Berwert L., Burnier M., Teta D., 2010. Revue Médicale Suisse, 6 (238) pp. 432-437.
[Pmid][serval:BIB_37FDC60B93CF]
 
Insuffisance rénate chronique: attitudes et pratiques de dépistages en l'absence d'etudes randomisées. [Chronic kidney disease: screening attitude and practice in the absence of randomized controlled trials].
Ponte Belén, Martin Pierre-Yves, Pechère Antoinette, Burnier Michel, Guessous Idris, 2010. Revue Médicale Suisse, 6 (256) pp. 1400-1404.
[Pmid][serval:BIB_9FF24D667A77]
 
La nutrition et le métabolisme dans les maladies rénales [Nutrition and metabolism in kidney disease].
Martin P.Y., Teta D., Burnier M., 2010. Revue Médicale Suisse, 6 (238) pp. 427-428.
[Pmid][serval:BIB_0B794D7D9D04]
Le traitement pharmacologique de l'hypertension artérielle est-il bénéfique chez les personnes âgées? : revue Cochrane pour le praticien
Santschi Valérie, Burnier Michel, Peytremann Bridevaux Isabelle, 2010. Revue médicale suisse, 6 (242) p. 688.
[URN][serval:BIB_17B19802529B]
 
Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population.
Wuerzner G., Pruijm M., Maillard M., Bovet P., Renaud C., Burnier M., Bochud M., 2010. American Journal of Kidney Diseases, 56 (2) pp. 303-312.
[DOI][WoS][Pmid][serval:BIB_97571C7A2BBF]
 
Neuroendocrine characterization and anorexigenic effects of telmisartan in diet- and glitazone-induced weight gain.
Aubert Gregory, Burnier Michel, Dulloo Abdul, Perregaux Christine, Mazzolai Lucia, Pralong Francois, Zanchi Anne, 2010. Metabolism: Clinical and Experimental, 59 (1) pp. 25-32. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_30E656105251]
 
Prevalences of masked and white-coat hypertension in the Lausanne population: the Hercules Study
Bochud Murielle, Vollenweider Peter, Maillard Marc, Barreau Yolande, Paccaud Fred, Burnier Michel, 2010. pp. e5 dans 20th Annual Meeting of the European Society of Hypertension, Journal of Hypertension. Peer-reviewed.
[DOI][WoS][serval:BIB_58615B49406D]
 
Quand référer aux urgences un patient présentant une elévation sévère de la pression artérielle [When should a patient with severe hypertension be referred to the emergency ward?].
Clerc D., Wuerzner G., Burnier M., 2010. Revue Médicale Suisse, 6 (259) pp. 1530-1534.
[Pmid][serval:BIB_0FA00EB688B8]
 
Role of the NALP3 Inflammasome in the Development of Two-Kidney, One Clip Hypertension in Mice
Wang Q., Mordasini D., Tschopp J., Burnier M., So A., 2010. pp. E391 dans 20th Annual Meeting of the European-Society-of-Hypertension, Journal of Hypertension. Peer-reviewed.
[WoS][serval:BIB_7A4C7F229465]
 
Résistance aux diurétiques de l'anse en clinique [Resistance to loop diuretics in clinical practice]
Gobin N., Coltamai L., Burnier M., Vogt B., 2010. Revue Médicale Suisse, 6 (238) pp. 438-442.
[Pmid][serval:BIB_60F6355B05F1]
 
Traiter l'hypertension artérielle: l'incertitude des définitions et des cibles [Managing hypertension: the uncertainty of definitions and targets].
Forni V., Wuerzner G., Pruijm M., Guihard L., Burnier M., 2010. Revue Médicale Suisse, 6 (262) pp. 1709-1714.
[Pmid][serval:BIB_52178A95FBD7]
 
Treating high blood pressure: is reaching the target more important than the means? No, the means are important.
Forni V., Wuerzner G., Pruijm M., Burnier M., 2010. European Journal of Internal Medicine, 21 (6) pp. 478-483.
[DOI][WoS][Pmid][serval:BIB_7A595F4BCA2B]
2009
 
Association between white-coat effect and blunted dipping of nocturnal blood pressure.
Bochud M., Bovet P., Vollenweider P., Maillard M., Paccaud F., Wandeler G., Gabriel A., Burnier M., 2009/10. American journal of hypertension, 22 (10) pp. 1054-1061. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_986B38CD8370]
Prevalence of microalbuminuria and its associated cardiovascular risk: German and Swiss results of the recent global i-SEARCH survey.
Tebbe U., Bramlage P., Thoenes M., Paar W.D., Danchin N., Volpe M., Schrader J., Noll G., Burnier M., Böhm M., 2009/08/22. Swiss medical weekly, 139 (33-34) pp. 473-480. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3556A98968B3]
 
Aldosterone and cardiovascular risk.
Vogt Bruno, Burnier Michel, 2009. Current Hypertension Reports, 11 (6) pp. 450-455.
[DOI][WoS][Pmid][serval:BIB_D67D5AAAEA92]
 
Calcium-sensing receptors modulate renin release in vivo and in vitro in the rat.
Maillard M.P., Tedjani A., Perregaux C., Burnier M., 2009. Journal of Hypertension, 27 (10) pp. 1980-1987.
[DOI][WoS][Pmid][serval:BIB_8725B8D77CC8]
Citrate- vs. acetate-based dialysate in bicarbonate haemodialysis: consequences on haemodynamics, coagulation, acid-base status, and electrolytes.
Gabutti Luca, Lucchini Barbara, Marone Claudio, Alberio Lorenzo, Burnier Michel, 2009. BMC Nephrology, 10 p. 7.
[URN][DOI][WoS][Pmid][serval:BIB_82D7A3B4291F]
 
CYP3A5 and ABCB1 genes and hypertension.
Bochud M., Bovet P., Burnier M., Eap C.B., 2009. Pharmacogenomics, 10 (3) pp. 477-487. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4D26D0016704]
 
Dose-dependent acute and sustained renal effects of the endothelin receptor antagonist avosentan in healthy subjects.
Smolander J., Vogt B., Maillard M., Zweiacker C., Littke T., Hengelage T., Burnier M., 2009. Clinical Pharmacology and Therapeutics, 85 (6) pp. 628-634.
[DOI][WoS][Pmid][serval:BIB_11E8FF45CFE0]
 
Effect of Sodium Loading/Depletion on Renal Oxygenation in Young Normo-and Hypertensive Men Measured with BOLD-MRI
Pruijm M., Hofmann L., Maillard M., Tremblay S., Burnier M., Vogt B., 2009. pp. E69-E69 dans 63rd High Blood Pressure Research Conference, Hypertension. Peer-reviewed.
[WoS][serval:BIB_21BC93EF85B7]
 
Electronic monitors of drug adherence: tools to make rational therapeutic decisions
Santschi Valérie, Chiolero Arnaud, Burnier Michel, 2009. Journal of Hypertension, 27 (11) pp. 2294-2295. Peer-reviewed.
[DOI][WoS][serval:BIB_282F7035D0D9]
Ethnic differences in proximal and distal tubular sodium reabsorption are heritable in black and white populations.
Bochud M., Staessen J.A., Maillard M., Mazeko M.J., Kuznetsova T., Woodiwiss A., Richart T., Norton G., Thijs L., Elston R. et al., 2009. Journal of Hypertension, 27 (3) pp. 606-612. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_96D9B390AF53]
Glomerular hyperfiltration and increased proximal sodium reabsorption in type 2 diabetes in a middle-income country in the African region
Pruijm Menno T., Würzner Grégoire, Maillard Marc P., Bovet Pascal, Renaud C., Bochud Murielle, Burnier Michel, 2009. pp. S29 dans Abstract book, 19th European Meeting on Hypertension, Milan, June 12-16, 2009.
[URN][serval:BIB_B35982CA3263]
 
Génétique et hypertension artérielle: qu'avons nous-appris ? [Hypertension genetics: what have we learned so far?]
Pruijm Menno, Bochud Murielle, Burnier Michel, 2009. Revue médicale suisse, 5 (216) pp. 1763-1770.
[Pmid][serval:BIB_08D09CB0B949]
Haemodialysis acutely reduces the plasma levels of ADMA without reversing impaired NO-dependent vasodilation.
Engelberger R.P., Teta D., Henry H., De Senarclens O., Dischl B., Liaudet L., Burnier M., Waeber B., Feihl F., 2009. Clinical Science, 117 (7-8) pp. 293-303.
[URN][DOI][WoS][Pmid][serval:BIB_DB929680ECA0]
Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids.
Gabutti L., Bianchi G., Soldini D., Marone C., Burnier M., 2009. Nephrology, Dialysis, Transplantation, 24 (3) pp. 973-981.
[URN][DOI][WoS][Pmid][serval:BIB_894F379AE4B9]
 
Hypernatriämie--wie weiter [Hypernatremia]
Vogt B., Berwert L., Burnier M., 2009. Therapeutische Umschau. Revue Thérapeutique, 66 (11) pp. 753-757.
[DOI][Pmid][serval:BIB_69A081CD284F]
 
Hypertension 2009: quoi de neuf [Hypertension 2009: what's new?].
Burnier M., Waeber B., Pechère-Bertschi A., 2009. Revue Médicale Suisse, 5 (216) pp. 1747-1748.
[Pmid][serval:BIB_5C6E31B00AB5]
 
Improvement in secondary hyperparathyroidism due to drug adherence monitoring in dialysis patients.
Pruijm M., Teta D., Halabi G., Wuerzner G., Santschi V., Burnier M., 2009. Clinical Nephrology, 72 (3) pp. 199-205. Peer-reviewed.
[WoS][Pmid][serval:BIB_3C8594EAA23A]
 
Independent relations of left ventricular structure with the 24-h urinary excretion of sodium and aldosterone
Yu Jin, Kuznetsova Tatiana, Maillard Marc, Richart Tom, Thijs Lutgarde, Bochud Murielle, Herregods Marie-Christine, Burnier Michel, Fagard Robert, Staessen Jan A., 2009. p. 82 dans 15th European Meeting on Hypertension, International Journal of Cardiology. Peer-reviewed.
[DOI][WoS][serval:BIB_DDE49C9E4B6B]
 
Independent relations of left ventricular structure with the 24-hour urinary excretion of sodium and aldosterone.
Jin Y., Kuznetsova T., Maillard M.P., Richart T., Thijs L., Bochud M., Herregods M.C., Burnier M., Fagard R., Staessen J.A., 2009. Hypertension, 54 (3) pp. 489-495. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3417CA67D9C9]
 
Is it appropriate to index glomerular filtration rate for body surface area
Wuerzner G., Pruijm Menno, Maillard Marc, Bovet Pascal, Renaud Claude, Bochud Murielle, Burnier Michel, 2009. pp. 4S-5S dans Annual meeting of the Swiss Society of Nephrology, Interlaken (Switzerland), December 2-4, 2009, Swiss Medical Weekly. Peer-reviewed.
[serval:BIB_D59483FDF922]
 
Issues in blood pressure control and the potential role of single-pill combination therapies.
Burnier M., Brown R.E., Ong S.H., Keskinaslan A., Khan Z.M., 2009. International Journal of Clinical Practice, 63 (5) pp. 790-798.
[DOI][WoS][Pmid][serval:BIB_35DE21B467A2]
 
L'hypertension chez les transplantés d'organes [Hypertension in solid organ transplants].
Glatz N., Wuerzner G., Pruijm M., Golshayan D., Burnier M., 2009. Revue Médicale Suisse, 5 (216) pp. 1771-1777.
[Pmid][serval:BIB_EAA76D40DD9D]
 
L'hémodialyse intermittente aux soins intensifs = [Intermittent hemodialysis in the intensive care setting]
Kissling S., Schneider A., Eggimann P., Qué Y.A., Burnier M., Vogt B., 2009. Revue Médicale Suisse, 5 (192) pp. 445-450.
[Pmid][serval:BIB_6A4842DD22D3]
 
L'importance de la détection précoce de l'insuffisance rénale chronique [The importance of early detection of chronic renal insufficiency].
Martin P.Y., Burnier M., 2009. Revue Médicale Suisse, 5 (192) pp. 435-436.
[Pmid][serval:BIB_B5D5609ACAAE]
 
La néphropathie ischémique par athérosclérose aortorénale : acquisitions thérapeutiques [Atherosclerotic renal artery disease management update]
Meier P., Haesler E., Teta D., Qanadli S.D., Burnier M., 2009. Néphrologie & Thérapeutique, 5 (1) pp. 13-24. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F36FF28D9492]
 
La néphropathie ischémique par athérosclérose aortorénale : diagnostic [Atherosclerotic renal artery disease diagnosis update].
Meier P., Haesler E., Teta D., Qanadli S.D., Burnier M., 2009. Néphrologie & Thérapeutique, 5 (1) pp. 1-12.
[DOI][WoS][Pmid][serval:BIB_6C70EF7425B4]
 
Left ventricular structure in relation to aldosterone and renal segmeental sodium handling
Jin Yu, Kuznetsova Tatiana, Maillard Marc, Richart Tom, Thijs Lutgarde, Bochud Murielle, Herregods Marie-Christine, Burnier Michel, Fagard Robert, Staessen Jan A, 2009. Acta Clinica Belgica, 64 (2) pp. 165-166. Peer-reviewed.
[serval:BIB_3690C3184C6A]
Left ventricular structure in relation to aldosterone and renal segmental sodium handling
Jin Yu, Kuznetsova Tatiana, Maillard Marc P., Richart Tom, Thijs Lutgarde, Bochud Murielle, Herregods Marie-Christine, Burnier Michel, Fagard Robert, Staessen Jan A., 2009. pp. S317 dans Abstract book, 19th European Meeting on Hypertension, Milan, June 12-16, 2009.
[URN][serval:BIB_532CC8D802C7]
 
Les conséquences rénales de l'anorexie [Anorexia nervosa and the kidney].
Schneiter S., Berwert L., Bonny O., Teta D., Burnier M., Vogt B., 2009. Revue Médicale Suisse, 5 (192) pp. 440-444.
[Pmid][serval:BIB_EE60286C5F95]
 
Less frequent dosing of erythropoiesis stimulating agents in patients undergoing dialysis: a European multicentre cost study.
Burnier M., Douchamps J.A., Tanghe A., Demey J., Perrault L., Foster C.E., Robbins S., 2009. Journal of Medical Economics, 12 (2) pp. 77-86.
[DOI][Pmid][serval:BIB_12EE06773040]
 
Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD.
Meier P., Golshayan D., Blanc E., Pascual M., Burnier M., 2009. Journal of the American Society of Nephrology, 20 (6) pp. 1368-1384.
[DOI][WoS][Pmid][serval:BIB_70AF63850752]
 
Parameters for successful monthly extended dosing of darbepoetin-alpha in patients undergoing hemodialysis.
Trachsler J., Glück Z., Dickenmann M., Gauthier T., Brünisholz M., Martin P.Y., Burnier M., Wahl C., Wüthrich R.P., 2009. Clinical Nephrology, 71 (6) pp. 697-702.
[WoS][Pmid][serval:BIB_6D5143ADBBE0]
 
Problèmes dus aux fistules d'hémodialyse: un réseau régional de prise en charge [Problems related to haemodialysis vascular accesses: a regional network of care]
Imsand D., Teta D., Saucy F., Doenz F., Qanadli S.D., Corpataux J.M., Burnier M., Mazzolai L., Haesler E., 2009. Revue Médicale Suisse, 5 (189) pp. 294-298.
[Pmid][serval:BIB_FDBC1FF84752]
 
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.
Mancia Giuseppe, Laurent Stephane, Agabiti-Rosei Enrico, Ambrosioni Ettore, Burnier Michel, Caulfield Mark J., Cífková Renata, Clement Denis, Coca Antonio, Dominiczak Anna et al., 2009. Journal of Hypertension, 27 (11) pp. 2121-2158.
[DOI][WoS][Pmid][serval:BIB_28F3DA4B256F]
 
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.
Mancia Giuseppe, Laurent Stephane, Agabiti-Rosei Enrico, Ambrosioni Ettore, Burnier Michel, Caulfield Mark J., Cifkova Renata, Clement Denis, Coca Antonio, Dominiczak Anna et al., 2009. Blood Pressure, 18 (6) pp. 308-347.
[DOI][WoS][Pmid][serval:BIB_75A3FBD23F32]
Statines et insuffisance rénale chronique: un bon ménage? : revue Cochrane pour le praticien
Santschi Valérie, Burnier Michel, Peytremann Bridevaux Isabelle, 2009. Revue médicale suisse, 5 (218) p. 1903.
[URN][serval:BIB_57FE980CFCDC]
 
Tabagisme et rein [Smoking and the kidney]
El Housseini Y., Phan O., Burnier M., Vogt B., 2009. Revue Médicale Suisse, 5 (192) pp. 457-462. Peer-reviewed.
[Pmid][serval:BIB_1B49EE568D2D]
 
Telmisartan: a different angiotensin II receptor blocker protecting a different population?
Burnier Michel, 2009. Journal of International Medical Research, 37 (6) pp. 1662-1679.
[WoS][Pmid][serval:BIB_FBD9ACA9EC30]
The white coat effect is associated with reduced fall in nocturnal blood pressure
Bochud Murielle, Barreau Yolande, Maillard Marc P., Vollenweider Peter, Paccaud Fred, Burnier Michel, 2009. pp. S5 dans Abstract book, 19th European Meeting on Hypertension, Milan, June 12-16, 2009.
[URN][serval:BIB_B9DBC45884CD]
 
Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
Burnier M., Pruijm M., Wuerzner G., 2009. Expert Opinion on Drug Metabolism & Toxicology, 5 (8) pp. 981-987.
[DOI][WoS][Pmid][serval:BIB_0A400568CEFD]
Use of darbepoetin alfa in the treatment of anaemia of chronic kidney disease: clinical and pharmacoeconomic considerations.
Carrera F., Burnier M., 2009. NDT Plus, 2 (Suppl .1) pp. i9-i17.
[URN][DOI][Pmid][serval:BIB_17BA49D0AEDA]
 
Vascular effects of RWJ-676070, a selective combined V1a/V2 vasopressin receptor antagonist.
Coltamai L., Bucher M., Maillard M.P., Shukla U., Bohidar N., Haskell L., Bertelsen K., Fedgchin M., Vogt B., Burnier M., 2009. Clinical Pharmacology and Therapeutics, 85 (2) pp. 145-148. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BC36EA0F8224]
2008
 
Prevalence of microalbuminuria in the general population of Seychelles and strong association with diabetes and hypertension independent of renal markers.
Pruijm M.T., Madeleine G., Riesen W.F., Burnier M., Bovet P., 2008/05. Journal of hypertension, 26 (5) pp. 871-877. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A246C626D001]
 
A new measurement of energy expenditure and physical activity in patients treated by maintenance hemodialysis
Deléaval Patrik, Zweiacker Carole, Bochud Murielle, Burnier Michel, Teta Daniel, 2008. pp. 8S-9S dans 40th Annual Meeting Swiss Society of Nephrology, St. Gallen, December 3-5, 2008, Swiss Medical Weekly. Peer-reviewed.
[serval:BIB_C21EC7B6824A]
 
Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories
Vrijens B., Vincze G., Kristanto P., Urquhart J., Burnier M., 2008. BMJ, 336 (7653) pp. 1114-1117.
[DOI][WoS][Pmid][serval:BIB_A9A31B397FBC]
 
Age-dependent of serum acid with blood pressure and renal function - The Colaus study
Bochud M., Burnier M., Marques-Vidal P., Firmann M., Waeber G., Waterworth D., Mooser V., Vollenweider P., 2008. pp. S125-S125 dans 8th Scientific Meeting of the European-Society-of-Hypertension/22nd Scientific Meeting of the International-Society-of-Hypertension, Journal of Hypertension. Peer-reviewed.
[WoS][serval:BIB_B10A37286541]
 
Alterations of renal sodium handling in arterial hypertension.
Burnier M., 2008. Current Hypertension Reports, 10 (2) pp. 85-86. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A35301DB0CE8]
Association of ABCB1 genetic variants with renal function in Africans and in Caucasians.
Bochud M., Eap C.B., Maillard M., Johnson T., Vollenweider P., Bovet P., Elston R.C., Bergmann S., Beckmann J.S., Waterworth D.M. et al., 2008. BMC Medical Genomics, 1 (21) pp. 1-11. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D784077998C6]
 
Behandlung der kardiovaskularen Hochrisikopatienten: Bestatigung und Uberraschung in der ONTARGET-Studie SB - IM [Treatment of patients at high cardiovascular risk: confirmation and surprising results of the ONTARGET-Study]
Burnier M., Waeber B., Hess O., Lüscher T., 2008. Praxis, 97 (10) pp. 559-562.
[Pmid][serval:BIB_014AAF1AF244]
 
Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4
Staessen J. A., Kuznetsova T., Zhang H., Maillard M., Bochud M., Hasenkamp S., Westerkamp J., Richart T., Thijs L., Li X. et al., 2008. Hypertension, 51 (6) pp. 1643-1650. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9221AB3DE4AD]
 
Blood pressure modifies the association between serum adiponectin and uric acid, in a sex-dependent manner
Bochud Murielle, Marques-Vidal Pedro Manuel, Vollenweider Peter, Mooser Vincent, Waeber Gérard, Paccaud Fred, Burnier Michel, Teta Daniel, 2008. pp. 10S dans 40th Annual Meeting Swiss Society of Nephrology, St. Gallen, December 3-5, 2008, Swiss Medical Weekly. Peer-reviewed.
[serval:BIB_B789F7DFE7FD]
 
Defective ENaC processing and function in tissue kallikrein-deficient mice.
Picard N., Eladari D., El Moghrabi S., Planès C., Bourgeois S., Houillier P., Wang Q., Burnier M., Deschenes G., Knepper M.A. et al., 2008. Journal of Biological Chemistry, 283 (8) pp. 4602-4611. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_97505D167AF9]
 
Drug-induced alterations of sodium balance: the example of nonsteroidal anti-inflammatory agents
Maillard M., Burnier M., 2008. pp. 381-396 dans M. Burnier (eds.) Sodium in Health Disease chap. 20, Informa Healthcare.
[serval:BIB_37DDAA4FCA1E]
 
End-digit preference in general practice: A comparison of the conventional auscultatory and electronic oscillometric methods
Burnier M., Gasser U. E., 2008. Blood Press, 17 (2) pp. 104-109.
[DOI][WoS][Pmid][serval:BIB_9744006B7081]
 
Estimation de la fonction rénale par l'equation MDRD: intérêt et limites pour l'adaptation des doses de médicaments [Renal function estimation by MDRD equation: interest and limitations for drug dosing].
Livio F., Biollaz J., Burnier M., 2008. Revue Médicale Suisse, 4 (181) pp. 2596-2600.
[Pmid][serval:BIB_4BEE75947F22]
 
Ethnic Differences in Renal Handling of Water and Solutes in Hypertension
Burnier M., 2008. Hypertension.
[DOI][WoS][Pmid][serval:BIB_6CDE357829B7]
 
Hormonal control of sodium balance
Burnier M., Coltamai L., Vogt B., 2008. pp. 103-125 dans M. Burnier (eds.) Sodium in Health Disease chap. 5, Informa Healthcare.
[serval:BIB_82E397FFD198]
 
Impact of electronic monitoring of drug adherence on blood pressure control in primary care: a cluster 12-month randomised controlled study.
Santschi V., Rodondi N., Bugnon O., Burnier M., 2008. European Journal of Internal Medicine, 19 (6) pp. 427-434. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B7B9216203EB]
 
Improving anemia management with less frequently dosed erythropoiesis stimulating agents
Burnier M., Demay J., Tanghe A., Douchamps J., 2008. pp. 199-200 dans 44th ERA-EDTA Congress, Nephrology Dialysis Transplantation. Peer-reviewed.
[WoS][serval:BIB_3E8A36171183]
 
La génétique de l'hypertension: rôle des gènes CYP3A5 et ABCB1 dans le contrôle de la tension artérielle
Bochud Murielle, Eap Chin B., Bovet Pascal, Burnier Michel, 2008. Kardiovaskuläre Medizin, 11 (11) pp. 353-360.
[serval:BIB_178322875288]
 
La plasmaphérèse: technique, complications et indications [Plasmapheresis: technique, complications and indications]
Pruijm M.T., Cherpillod A., Vogt B., Burnier M., 2008. Revue Médicale Suisse, 4 (147) pp. 581-582, 584-586, 588.
[Pmid][serval:BIB_8F0E918E4792]
 
Low adiponectin is associated with increased ambulatory pulse pressure and activation of the renin-angiotensin system in subjects of African descent
Reyna-Carmona Laura-Elena, Bochud Murielle, Maillard Marc P., Bovet Pascal, Nussberger Jürg, Burnier Michel, Teta Daniel, 2008. pp. 10S dans 40th Annual Meeting Swiss Society of Nephrology, St. Gallen, December 3-5, 2008, Swiss Medical Weekly. Peer-reviewed.
[serval:BIB_CB5D4268F4C1]
 
Mesure de la pression artérielle et dépistage de l'hypertension chez l'enfant. [Blood pressure measurement and screening of hypertension in children].
Chiolero A., Burnier M., Paradis G., Paccaud F., Bovet P., 2008. Revue Médicale Suisse, 4 (170) pp. 1904-1909. Peer-reviewed.
[Pmid][serval:BIB_85FB3BED5928]
 
Need to clarify when measurements should be made during the day for home blood pressure monitoring.
Bovet Pascal, Chiolero Arnaud, Burnier Michel, Paccaud Fred, 2008. Journal of hypertension, 26 (1) pp. 154-155. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B9C74E05EF99]
 
Nighttime blood pressure and nocturnal dipping are associated with daytime urinary sodium excretion in african subjects
Bankir Lise, Bochud Murielle, Maillard Marc, Bovet Pascal, Gabriel Anne, Burnier Michel, 2008. Hypertension, 51 (4) pp. 891-898. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9A96D295626C]
 
Nocturnal blood pressure fall changes in correlation with urinary sodium excretion.
Ortega K.C., da Silva G.V., Mion D., 2008. Hypertension, 52 (2) pp. e10; author reply e11. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9B571450F43E]
 
Nutzen einer antihypertensiven Therapie bei über 80-Jährigen [Need of antihypertensive therapy in patients aged 80 years or more]
Waeber B., Burnier M., Lüscher T., Hess O., 2008. Praxis, 97 (10) pp. 563-566.
[Pmid][serval:BIB_02C8A2FCA5E5]
Optimal and continuous anaemia control in a cohort of dialysis patients in Switzerland.
Mathieu C.M., Teta D., Lötscher N., Golshayan D., Gabutti L., Kiss D., Martin P.Y., Burnier M., 2008. BMC Nephrology, 9 (16) p. 16. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B60EC0191F1F]
Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine.
Pruijm M.T., Maillard M.P., Burnier M., 2008. Vascular Health and Risk Management, 4 (6) pp. 1159-1166.
[URN][Pmid][serval:BIB_9A021E2085AA]
 
Place de ta vitamine D, du sevelamer et du cinacalcet dans la prise en charge des patients en insuffisance rénale [Treatment of secondary hyperparathyroidism in renal insufficiency: role of calcitriol, sevelamer and cinacalcet]
Bonny O., Burnier M., 2008. Revue Médicale Suisse, 4 (147) pp. 589-92, 594-5.
[Pmid][serval:BIB_B8FFEE76BE39]
 
Plasmaferese : veilig bij een goede indicatiestelling en kennis van de complicaties [Plasmapheresis, a safe treatment when applied to the correct indication and with awareness of the complications]
Pruijm M.T., Vogt B., Cherpillod A., Burnier M., 2008. Nederlands Tijdschrift voor Geneeskunde, 152 (42) pp. 2261-2266.
[Pmid][serval:BIB_DB84932BD5C9]
 
Position of diuretics in the management of hypertension
Waeber B., Burnier M., 2008. pp. 397-416 dans M. Burnier (eds.) Sodium in Health Disease, Informa Healthcare.
[serval:BIB_DFF1FA0591F2]
 
Prevalence of hypertension in school children: reply
Chiolero Arnaud, Paccaud Fred, Burnier Michel, Bovet Pascal, 2008. Journal of Hypertension, 26 (3) pp. 611-612. Peer-reviewed.
[DOI][serval:BIB_EFF69DFA4E5C]
 
Prise en charge de l'hypertension arterielle: ne pas baisser la garde! [Treating arterial hypertension: do not lower your attention!]
Burnier M., Waeber B., Bertschi A.P., 2008. Revue Médicale Suisse, 4 (170) pp. 1899-1900.
[Pmid][serval:BIB_80FF3149857B]
 
Public health value of fixed-dose combinations in hypertension.
Ruilope L.M., Burnier M., Muszbek N., Brown R.E., Keskinaslan A., Ferber P., Harms G., 2008. Blood Pressure. Supplement, 1 pp. 5-14.
[WoS][Pmid][serval:BIB_53327880BE80]
 
Quel futur pour la néphrologie et les néphrologues [What is the future of nephrology for nephrologists?]
Burnier M., Martin P.Y., 2008. Revue Médicale Suisse, 4 (147) pp. 563-564.
[Pmid][serval:BIB_7FF72CE25B65]
 
Relationships among endogenous ouabain, alpha-adducin polymorphisms and renal sodium handling in primary hypertension.
Manunta P., Maillard M., Tantardini C., Simonini M., Lanzani C., Citterio L., Stella P., Casamassima N., Burnier M., Hamlyn J.M. et al., 2008. Journal of Hypertension, 26 (5) pp. 914-920. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E0342915E14B]
 
Retroperitoneale Fibrose, Morbus Ormond, chronische Periaortitis, ... [Retroperitoneal fibrosis, M. Ormond, periaoartitis, ...?]
Vogt B., Meier P., Burnier M., 2008. Therapeutische Umschau, 65 (5) pp. 265-268.
[DOI][Pmid][serval:BIB_2B05004790CB]
 
Salt and blood pressure: the concept of salt sensitivity
Bochud M., Burnier M., 2008. pp. 267-292 dans M. Burnier (eds.) Sodium in Health Disease chap. 14, Informa Healthcare.
[serval:BIB_BF8B905109B6]
 
Salt and blood pressure: the concept of salt sensitivity.
Bochud Murielle, Burnier Michel, 2008. pp. 267-292 dans Burnier Michel (eds.) Sodium in health and disease chap. 14, Informa Healthcare.
[serval:BIB_DCADDF20D987]
 
Segmental renal sodium handling in relation to the human SAH gene.
Jin Y., Kuznetsova T., Tikhonoff V., Maillard M., Bochud M., Burnier M., Hasenkamp S., Brand E., Brand-Herrmann S.M., Richart T. et al., 2008. Hypertension, 52 (2) pp. e12-3. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2801ABBBDF6A]
 
Sodium in Health Disease.
Burnier M., 2008., Informa Healthcare, Burnier M..
[serval:BIB_1D7E9BA41EB7]
 
Sténose de l'artère rénale: indications pour une revascularisation [Atherosclerotic renal stenosis: indications for revascularisation]
Phan O., Burnier M., Waeber B., 2008. Revue Médicale Suisse, 4 (170) pp. 1918-1913. Peer-reviewed.
[Pmid][serval:BIB_80A7BA9199F6]
 
Suivi de l'adhésion thérapeutique des patients hypertendus ou dyslipi- démiques par les cercles de qualité médecins-pharmaciens [Monitoring drug adherence for hypertensive and dyslipidemic patients in networks of community-based pharmacists and physicians].
Santschi V., Rodondi N., Bugnon O., Pannatier A., Burnier M., 2008. Revue Médicale Suisse, 4 (170) pp. 1928-1936.
[Pmid][serval:BIB_18AE6A6FCBB1]
 
The leptin/adiponectin ratio: potential implications for peritoneal dialysis.
Teta D., Maillard M., Halabi G., Burnier M., 2008. Kidney International., 108 (Supplement) pp. S112-S118.
[DOI][WoS][Pmid][serval:BIB_B884DE2A1EDF]
 
The metabolic syndrome in hypertension: European society of hypertension position statement.
Redon J., Cifkova R., Laurent S., Nilsson P., Narkiewicz K., Erdine S., Mancia G., Scientific Council of the European Society of Hypertension, 2008. Journal of Hypertension, 26 (10) pp. 1891-1900.
[DOI][WoS][Pmid][serval:BIB_E5760A08472B]
 
Traitement de l'hyperparathyroïdisme secondaire en dialyse : à propos d'un cas d'inefficacité apparente du traitement médicamenteux [Treatment of secondary hyperparathyroidism in dialysis: Report of a case-study of treatment failure]
Pruijm M.T., Teta D., Wuerzner G., Santschi V., Burnier M., 2008. Néphrologie Thérapeutique, 4 (1) pp. 28-33. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CEB684FF6F7D]
2007
 
Efficacy and tolerability of lercanidipine in patients with hypertension: results of a Phase IV study in general practice
Burnier M., Gasser U. E., 2007/10. Expert Opinion on Pharmacotherapy, 8 (14) pp. 2215-23.
[DOI][WoS][Pmid][serval:BIB_ED65EBDA0A15]
Clinical evaluation of IDAS II, a new electronic device enabling drug adherence monitoring.
Santschi V., Wuerzner G., Schneider M.P., Bugnon O., Burnier M., 2007/09. European Journal of Clinical Pharmacology, 63 (2) pp. 1179-1184.
[URN][DOI][WoS][Pmid][serval:BIB_E5FA08C59DB3]
High salt intake: a cause of blood pressure-independent left ventricular hypertrophy?
Burnier M., Phan O., Wang Q., 2007/09. Nephrology, Dialysis, Transplantation, 22 (9) pp. 2426-9.
[URN][DOI][WoS][Pmid][serval:BIB_DE9805B28943]
 
Hypertension and the kidney: new avenues for an improved management of hypertension in renal diseases: introduction
Burnier M., 2007/09. Seminars in Nephrology, 27 (5) pp. 509-10.
[DOI][WoS][Pmid][serval:BIB_4DE423EB28BB]
Improving blood pressure control in the community: can new technologies help us?
Burnier M., 2007/09. American Journal of Hypertension, 20 (9) p. 949.
[URN][DOI][WoS][Pmid][serval:BIB_799A9BBAFD04]
 
Quelles sont les implications cliniques de la pression arterielle nocturne? [What are the clinical implications of nocturnal blood pressure?]
Burnier M., 2007/09. Revue Médicale Suisse, 3 (124) pp. 2007-10.
[Pmid][serval:BIB_BD7FA15451AB]
 
Vitamine D et hypertension: quel lien? [Vitamin D and hypertension, is there a link?]
Phan O., Burnier M., 2007/09. Revue Médicale Suisse, 3 (124) pp. 2022-4, 2026.
[Pmid][serval:BIB_9F5E4B14573B]
 
Telmisartan prevents the glitazone-induced weight gain without interfering with its insulin-sensitizing properties
Zanchi A., Dulloo A. G., Perregaux C., Montani J. P., Burnier M., 2007/07. American Journal of Physiology - Endocrinology and Metabolism, 293 (1) pp. E91-5. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_102CD43DB74E]
 
Renal sodium handling in patients with normal pressure glaucoma.
Pechere-Bertschi A., Sunaric-Megevand G., Haefliger I., Panarello F., Maillard M., Burnier M., 2007/06. Clinical Science, 112 (6) pp. 337-344. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6D050E72A451]
Atherosclerotic renovascular disease: beyond the renal artery stenosis
Meier P., Rossert J., Plouin P. F., Burnier M., 2007/04. Nephrology, Dialysis, Transplantation, 22 (4) pp. 1002-6.
[URN][DOI][WoS][Pmid][serval:BIB_582DFA80D734]
 
Anciens et nouveaux concepts dans le traitement de l'hyponatremie symptomatique. [Previous and new concepts in the management of symptomatic hyponatraemia]
Kissling S., Vogt B., Burnier M., 2007/03. Revue Médicale Suisse, 3 (101) pp. 583-4, 586-7.
[Pmid][serval:BIB_1CAE6C5840BF]
 
Les etudes randomisees controlees ne confirment pas toujours les resultats suggeres par les etudes observationnelles. [Controlled randomized studies do not always confirm the results suggested by observational studies]
Martin P. Y., Burnier M., 2007/03. Revue Médicale Suisse, 3 (101) pp. 571-2.
[Pmid][serval:BIB_CC773F6E760C]
 
Maladies renales et grossesse. [Pregnancy in patients with underlying renal disease]
Golshayan D., Mathieu C., Burnier M., 2007/03. Revue Médicale Suisse, 3 (101) pp. 588, 590-2, 594-5.
[Pmid][serval:BIB_62618F38A443]
The effect of pH-neutral peritoneal dialysis fluids on adipokine secretion from cultured adipocytes
Teta D., Maillard M., Tedjani A., Passlick-Deetjen J., Burnier M., 2007/03. Nephrology, Dialysis, Transplantation, 22 (3) pp. 862-9.
[URN][DOI][WoS][Pmid][serval:BIB_BDD65D2A0F8B]
 
ACE-Hemmer und Angiotensin-II-Rezeptor-Blocker
Vogt B., Bullani R., Burnier M., 2007. pp. 501-505 dans E. Battegay , G. Noseda , W. F. Riesen (eds.) Atherioskleroseprävention: Diagnostik und Therapie von Risikofaktoren, Hans Huber Verlag.
[serval:BIB_1E4CEF1017B2]
 
Angiotensin II receptor blockers: where do we stand ?
Burnier M., Maillard M., 2007. pp. 109-130 dans V. N. Pur , A. Ghatak (eds.) Perspectives in Hypertension, Allied Publishers Ltd.
[serval:BIB_64C69CE15855]
 
Anomalies du transport rénal du sodium et sensibilité au sel de la pression artérielle [Abnormalities of renal sodium transport and blood pressure sensitivity to salt].
Burnier M., 2007. Néphrologie et Thérapeutique, 3 Suppl 2 (Suppl. 2) pp. S94-S98. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B8DE0612E09D]
 
Betablocker
Burnier M., Bullani R., Vogt B., 2007. pp. 494-500 dans E. Battegay , G. Noseda , W. F. Riesen (eds.) Atheroskleroseprävention: Diagnostik Und Therapie von Risikofaktoren, Hans Huber Verlag.
[serval:BIB_CC13B4EB93E3]
 
Blockade of the renin-angiotensin system for renal protection: from history to future perspectives.
Burnier M., 2007. Journal of the Renin-Angiotensin-Aldosterone System, 8 (4) pp. 208-211. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C105FC7EFC2E]
 
Context dependency of serum and urinary lithium: implications for measurement of proximal sodium reabsorption.
Bochud M., Staessen J.A., Woodiwiss A., Norton G., Maillard M., Burnier M., 2007. Hypertension, 49 (5) pp. e34. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_156E214CD855]
 
CYP3A5 and ABCB1 genes influence blood pressure and response to treatment, and their effect is modified by salt.
Eap C.B., Bochud M., Elston R.C., Bovet P., Maillard M.P., Nussberger J., Schild L., Shamlaye C., Burnier M., 2007. Hypertension, 49 (5) pp. 1007-14. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_271777C1AEDD]
 
Encore et encore... de nouvelles recommandations dans le domaine de l'hypertension [Again and again...new recommendations for the management of hypertension]
Waeber B., Burnier M., Pechère-Bertschi A., 2007. Revue médicale suisse, 3 (124) pp. 1987-1988.
[Pmid][serval:BIB_D5397B322BFB]
 
Gonadal steroids, salt-sensitivity and renal function
Pechere-Bertschi A., Burnier M., 2007/01. Current Opinion in Nephrology and Hypertension, 16 (1) pp. 16-21.
[DOI][WoS][Pmid][serval:BIB_2D536454CD78]
 
Hypertension
Waeber B, Brunner HR, Burnier M, Cohn JN, 2007. pp. 1833-1883 dans Cardiovascular Medicine, Third Edition, James T. Willerson, Jay N. Cohn, Hein JJ. Wellens, David R. Holmes, Springer-Verlag.
[serval:BIB_CF0BE4AFE7E1]
 
Informed consent: true information or institutional review board-approved disinformation?
Rossel M., Burnier M., Stupp R., 2007. Journal of Clinical Oncology, 25 (36) pp. 5835-5836.
[DOI][WoS][Pmid][serval:BIB_28A9E3F2AC81]
Is the fixed-dose combination of telmisartan and hydrochlorothiazide a good approach to treat hypertension?
Maillard M.P., Burnier M., 2007. Vascular Health and Risk Management, 3 (3) pp. 265-278.
[URN][Pmid][serval:BIB_B6BBE5D04E31]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University